James E. Flynn, Ten Percent Owner Other at Recro Pharma, Inc. (REPH), sold 142,894 shares at $6.74 ($920K) on 2017-06-12, disclosed to the SEC on 2017-06-14.
Open-market sale of $920k REPH by Ten Percent Owner Other. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.74 | 10,000 | $67K | 7.3% |
| 2 | $6.59 | 32,447 | $214K | 23.2% |
| 3 | $6.59 | 32,447 | $214K | 23.2% |
| 4 | $6.25 | 68,000 | $425K | 46.2% |
| Total | $6.44 avg | 142,894 | $920K | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |